semaglutide how much to take Use Ozempic® Pen A new study suggests GLP-1s

Acne is a common problem that calls for a natural and long-term solution

Complete Guide to Retatrutide Retatrutide, Eli Lilly's triple-agonist drug targeting GLP-1, GIP, and glucagon, achieves 24.2% average body weight loss at 12 mg dose in 48 weeks, outperforming semaglutide (15%) and tirzepatide (20%)

Common side effects include mild nausea, vomiting, and constipation, typically managed by slow dose titration

David Rosenblum, MD, currently serves as the director of pain management at Maimonides Medical Center and managing partner of the multi-physician private pain practice, AABP Integrative Pain Care, both in Brooklyn, New York